Your browser is no longer supported. Please, upgrade your browser.
Settings
NURO NeuroMetrix, Inc. daily Stock Chart
NURO [NASD]
NeuroMetrix, Inc.
Index- P/E- EPS (ttm)-20.00 Insider Own2.00% Shs Outstand2.34M Perf Week-6.19%
Market Cap4.61M Forward P/E- EPS next Y-1.62 Insider Trans48.57% Shs Float2.08M Perf Month10.06%
Income-17.20M PEG- EPS next Q-1.90 Inst Own6.60% Short Float5.88% Perf Quarter-27.04%
Sales15.70M P/S0.29 EPS this Y6.10% Inst Trans36.14% Short Ratio2.54 Perf Half Y-60.93%
Book/sh3.59 P/B0.55 EPS next Y85.50% ROA-176.30% Target Price10.00 Perf Year-84.21%
Cash/sh1.54 P/C1.28 EPS next 5Y15.00% ROE-273.60% 52W Range1.66 - 13.28 Perf YTD-66.66%
Dividend- P/FCF- EPS past 5Y34.90% ROI- 52W High-85.17% Beta0.39
Dividend %- Quick Ratio1.70 Sales past 5Y3.00% Gross Margin40.20% 52W Low18.97% ATR0.12
Employees44 Current Ratio2.10 Sales Q/Q65.40% Oper. Margin-86.10% RSI (14)47.13 Volatility5.71% 5.84%
OptionableNo Debt/Eq0.00 EPS Q/Q94.20% Profit Margin- Rel Volume0.21 Prev Close2.01
ShortableYes LT Debt/Eq0.00 EarningsOct 19 BMO Payout- Avg Volume47.99K Price1.97
Recom2.00 SMA20-3.09% SMA50-2.12% SMA200-52.96% Volume10,118 Change-1.99%
Jun-28-16Initiated Rodman & Renshaw Buy $4.50
Sep-11-15Initiated Maxim Group Buy $2
Feb-27-12Initiated Dawson James Buy $3
Sep-18-17 03:37PM  Before You Buy NeuroMetrix Incs (NURO), You Should Consider This Simply Wall St.
Sep-05-17 01:00PM  NeuroMetrix Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City September 10-12th, 2017 Business Wire
Aug-31-17 03:32PM  Two Studies Derived from Quell Health Cloud to be Presented at Upcoming PAINWeek National Conference Business Wire
Aug-29-17 09:53AM  NeuroMetrix Teams Up with U.S. Pain Foundation to Raise Awareness of Chronic Pain Business Wire
Aug-17-17 07:40AM  Featured Company News - NeuroMetrix Announces Issuance of New US Patent for Automated Control of Quell(R) Therapy During Sleep ACCESSWIRE
Aug-15-17 07:00AM  NeuroMetrix Announces Issuance of New U.S. Patent for Automated Control of Quell Therapy During Sleep Business Wire
Aug-13-17 12:55AM  Edited Transcript of NURO earnings conference call or presentation 20-Jul-17 12:00pm GMT Thomson Reuters StreetEvents
Aug-03-17 10:13AM  NeuroMetrix Announces DPNCheck Distribution Agreement with Fukuda Denshi in Japan Business Wire
Jul-27-17 01:01PM  NeuroMetrix Announces Shipment of 100,000th Quell Device Since Launch in 2015 Business Wire
Jul-26-17 07:10AM  Featured Company News - FDA Gives Market Clearance to Teleflex's Arrow(R) Seldinger Arterial Catheterization Device Accesswire
Jul-24-17 11:41AM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q2, 2017 By the Numbers : July 24, 2017 Capital Cube +6.53%
Jul-20-17 07:00AM  NeuroMetrix Reports Q2 2017 Financial Results Business Wire -7.76%
06:10AM  Investor Network: NeuroMetrix, Inc. to Host Earnings Call Accesswire
Jul-13-17 07:00AM  NeuroMetrix, Inc. Announces Date for 2017 Second Quarter Financial Results Conference Call Business Wire
Jul-10-17 06:24PM  NeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock Business Wire
Jul-06-17 07:00AM  NeuroMetrix Reports Promotion of Michael MacDonald to Senior Vice President and General Manager of Diagnostics Business Wire
Jun-26-17 12:37PM  NeuroMetrix Provides Update on Quell Health Cloud Including Promotion of Dr. Xuan Kong to Chief Data Scientist Business Wire
Jun-23-17 11:05AM  NeuroMetrix Provides Update on Quell Wearable Pain Relief Clinical Program Business Wire
Jun-14-17 08:00AM  Today's Research Reports on Stocks to Watch: Cleantech Solutions and NeuroMetrix Accesswire -5.31%
Jun-13-17 07:00AM  NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology Business Wire
Jun-08-17 07:00AM  NeuroMetrix to Present at the Marcum Microcap Conference on June 16, 2017 Business Wire
Jun-06-17 09:42AM  NeuroMetrix Exhibits Quell Wearable Technology at 31st Annual SLEEP Meeting Business Wire
May-30-17 07:00AM  NeuroMetrix to Present at the LD Micro Invitational Conference on June 6, 2017 Business Wire
May-22-17 12:07PM  NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology Business Wire -6.77%
May-17-17 11:00AM  NeuroMetrix Wins SBANE New England Innovation Award Business Wire
May-16-17 08:00AM  NeuroMetrix Launches the LivingQuell Blog, a New Platform for Exploring Perspectives on Chronic Pain Business Wire
May-15-17 10:30AM  Preliminary Results from Clinical Study Evaluating Use of Quell in Chemotherapy-Induced Peripheral Neuropathy to be presented at the American Pain Society Annual Meeting Business Wire
May-11-17 11:45AM  NeuroMetrix Announces One-for-Eight Reverse Split Business Wire
May-08-17 11:04AM  NeuroMetrix Reports Substantial Expansion of International Intellectual Property Assets for Quell Wearable Pain Relief Technology Business Wire
May-05-17 01:02PM  NeuroMetrix Hosts Inaugural Quell User Event Business Wire
Apr-21-17 07:26PM  Edited Transcript of NURO earnings conference call or presentation 20-Apr-17 12:00pm GMT Thomson Reuters StreetEvents +5.69%
10:50AM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q1, 2017 By the Numbers : April 21, 2017 Capital Cube
Apr-20-17 07:00AM  NeuroMetrix Reports Q1 2017 Financial Results Business Wire -5.37%
Apr-19-17 08:30AM  NeuroMetrix Review Ahead of Thursday's Earnings Call Accesswire -5.65%
Apr-18-17 11:34AM  NeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Bed Bath & Beyond Business Wire +16.70%
Apr-13-17 10:00AM  NeuroMetrix Named a 50+ Innovation Leader Business Wire
Apr-12-17 10:52AM  NeuroMetrix, Inc. Announces Date for 2017 First Quarter Financial Results Conference Call Business Wire +5.26%
Mar-17-17 12:01PM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017 Capital Cube +6.25%
12:01PM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017
Mar-15-17 11:55AM  NeuroMetrix Brings Quell Wearable for Pain Relief to American Academy of Pain Medicine 33rd Annual Meeting Business Wire
Mar-01-17 12:20PM  NeuroMetrix Gaining Increased Media Coverage of Quell Wearable Pain Relief Technology in 2017 Business Wire
Feb-28-17 06:39PM  NEUROMETRIX, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -5.32%
Feb-21-17 11:00AM  NeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Best Buy Business Wire
Feb-15-17 01:04PM  NEUROMETRIX, INC. Financials
Feb-09-17 05:03PM  NEUROMETRIX, INC. Files SEC form 10-K, Annual Report
Feb-03-17 05:12PM  NEUROMETRIX, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard;
Jan-27-17 09:55AM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: 2016 By the Numbers : January 27, 2017 Capital Cube -5.83%
09:55AM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: 2016 By the Numbers : January 27, 2017
Jan-26-17 08:00AM  NeuroMetrix Inc Earnings Call scheduled for 8:00 am ET today +6.85%
07:09AM  NEUROMETRIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
07:07AM  Q4 2016 NeuroMetrix Inc Earnings Release - Before Market Open
07:00AM  NeuroMetrix Reports Q4 and Full Year 2016 Financial Results Business Wire
Jan-20-17 09:40AM  NeuroMetrix, Inc. Announces Date for 2016 Full Year and Fourth Quarter Financial Results Conference Call Business Wire
Jan-10-17 07:00AM  NeuroMetrix Reports Strong Quell Demand in Q4 2016 Business Wire +10.89%
Jan-06-17 09:25AM  NeuroMetrix to Present at the Digital Medicine Showcase 2017: At the Intersection of Technology and Medicine Business Wire
Jan-05-17 10:34AM  NeuroMetrix Closes $7.0 Million Private Placement of Preferred Stock and Warrants Business Wire
Jan-03-17 03:14PM  NeuroMetrix to Present at Biotech Showcase 2017 Business Wire
12:00PM  CES 2017: NeuroMetrix Brings Life-Enhancing Technology to Those Suffering from Chronic Pain Business Wire
Dec-29-16 06:03AM  NEUROMETRIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securit -7.31%
Dec-28-16 03:43PM  NeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock and Warrants Business Wire +11.55%
Dec-22-16 04:00PM  NeuroMetrix Announces Participation in CES 2017 Business Wire
Dec-20-16 08:00AM  NeuroMetrix Announces $26.5 Million Public Offering Business Wire -27.78%
Dec-15-16 11:00AM  NeuroMetrix Reports Expanded Media Coverage for Quell Wearable Pain Relief Business Wire
Dec-13-16 11:00AM  NeuroMetrix Announces That Quell Is Featured in Huffingtons New Thrive Global Platform Business Wire
Dec-12-16 10:51AM  NeuroMetrix President and Chief Executive Officer Dr. Gozani to Speak at 2016 Connected Health Conference Business Wire
Dec-08-16 02:44PM  NEUROMETRIX, INC. Files SEC form 8-K, Other Events +10.69%
Dec-07-16 12:05PM  NeuroMetrix Announces Quell Now Available on Amazon.com through Amazon Launchpad Business Wire
Nov-30-16 07:00AM  NeuroMetrix to Present at the LD Micro Invitational Conference on December 6, 2016 Business Wire -6.20%
Nov-29-16 07:00AM  NeuroMetrix Receives CE Mark Certification for Quell Wearable Pain Relief Device Business Wire -5.82%
Nov-22-16 10:05AM  NeuroMetrix Announces That Quell Will Be Featured on The Henry Ford Innovation Nation Business Wire -6.30%
Nov-16-16 07:00AM  NeuroMetrix Quell Device Makes Second Appearance at American Society of Regional Anesthesias Annual Pain Medicine Meeting Business Wire +6.09%
Nov-15-16 07:00AM  NeuroMetrix Reports DPNCheck Introduction at the Annual Meeting of the China Diabetes Society Business Wire
Nov-10-16 08:51AM  NeuroMetrix Chief Commercial Officer Frank McGillin to Present Quell Wearable Pain Relief Technology at 16th Annual Diabetes Technology Meeting Business Wire -5.83%
Nov-08-16 11:36AM  NeuroMetrix Announces Promotion of Frank McGillin to Chief Commercial Officer Business Wire
Oct-31-16 05:30PM  NEUROMETRIX, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Oct-27-16 07:00AM  NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology Business Wire
Oct-25-16 01:11PM  NeuroMetrix to Present at 2016 Sidoti Emerging Growth Convention Business Wire
Oct-24-16 10:52AM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q3, 2016 By the Numbers : October 24, 2016
Oct-20-16 01:48PM  Edited Transcript of NURO earnings conference call or presentation 20-Oct-16 12:00pm GMT
08:00AM  NeuroMetrix Inc Earnings Call scheduled for 8:00 am ET today
07:13AM  NEUROMETRIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
07:07AM  Q3 2016 NeuroMetrix Inc Earnings Release - Before Market Open
07:00AM  NeuroMetrix Reports Q3 2016 Financial Results Business Wire
Oct-18-16 01:02PM  NeuroMetrix Announces Participation at the 2016 Partners Connected Health Symposium Business Wire
Oct-13-16 01:50PM  NeuroMetrix, Inc. Announces Date for 2016 Third Quarter Financial Results Conference Call Business Wire
Oct-10-16 01:04PM  NeuroMetrix Announces Participation in Discover Blue: New York City Bluetooth Event Business Wire
Oct-06-16 12:44PM  NeuroMetrix to Present at 5th Annual Diabetic Peripheral Neuropathy Fellowship for Chinese Physicians at the University of Sheffield Business Wire
Oct-05-16 07:00AM  NeuroMetrix to Sponsor Study Assessing the Impact of Quell Technology on Chronic Low Back Pain Business Wire
Sep-28-16 11:43AM  NeuroMetrix Announces Frank McGillin Will Speak at the 2016 Wearable Technology Show Business Wire
Sep-22-16 07:00AM  NeuroMetrix Announces Quell Fibromyalgia Pilot with Synovation Medical Group Business Wire
Sep-20-16 07:00AM  NeuroMetrix Reports Progress on Quell Availability within the Veterans Health Administration Business Wire
Sep-16-16 12:39PM  NeuroMetrix Wins Electronics Retailer Association Award for Quell TV Advertising Business Wire
Sep-13-16 07:00AM  NeuroMetrix Reports Final Approval to Market DPNCheck in China Business Wire
Sep-08-16 07:00AM  NeuroMetrix Announces Quell Dispensing Partnership with Comprehensive Pain Specialists Business Wire
Sep-07-16 06:45PM  Weekly CFO Buys Highlights
Sep-06-16 11:00AM  NeuroMetrix Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016 Business Wire
Sep-01-16 11:44AM  NeuroMetrix Announces Issuance of Patent for DPNCheck Core Technology in China Business Wire +6.80%
Aug-30-16 07:00AM  NeuroMetrix Launches New Website to Support Growth of Quell Wearable Pain Relief Technology Business Wire
Aug-25-16 07:00AM  NeuroMetrix Announces That Quell Will Be Featured in the Target Open House Business Wire
Aug-22-16 12:21PM  NeuroMetrix Celebrates 10,000 Quell Facebook Fans with Pain Awareness Month Contest Business Wire
NeuroMetrix, Inc., a medical device company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes. Its marketed products include Quell, a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems; the SENSUS pain therapy device, a prescription neurostimulation device based on transcutaneous electrical nerve stimulation for relief of chronic intractable pain; DPNCheck, a test used to evaluate systemic neuropathies, such as diabetic peripheral neuropathy; and ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies. The company offers its products to consumers, patients, retail merchandisers, health care professionals, durable medical equipment suppliers, physicians, clinics, hospitals, managed care organizations, independent distributors, retail health businesses, endocrinologists, podiatrists, neurologists, and physical medicine and rehabilitation centers, as well as primary care, internal medicine, orthopedic, hand, and neuro surgeons primarily in the United States, Europe, Asia, the Middle East, and internationally. NeuroMetrix, Inc. was founded in 1996 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HIGGINS THOMAS TSenior Vice President, CFOJun 21Buy2.831,0002,83415,963Jun 21 04:16 PM
Gozani ShaiPresident & CEOJun 16Buy2.903,50010,14727,363Jun 16 12:58 PM
HIGGINS THOMAS TSenior Vice President, CFOJun 15Buy2.983,50010,41814,963Jun 15 04:11 PM
HIGGINS THOMAS TSenior Vice President, CFOJun 14Buy2.972,3006,82311,463Jun 14 03:01 PM
Gozani ShaiPresident & CEOJun 14Buy2.975,00014,87023,863Jun 14 03:02 PM
Gozani ShaiPresident & CEONov 01Buy1.313,0003,923150,909Nov 01 04:45 PM
HIGGINS THOMAS TSenior Vice President, CFOOct 28Buy1.323,0003,95173,309Oct 28 04:53 PM
Gozani ShaiPresident & CEOOct 27Buy1.326,0007,946147,909Oct 27 05:29 PM